Evoke Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.75M | Buy |
8,656
+998
| +13% | +$778K | 0.15% | 57 |
|
2025
Q1 | $6.32M | Buy |
7,658
+192
| +3% | +$159K | 0.17% | 62 |
|
2024
Q4 | $5.76M | Buy |
7,466
+211
| +3% | +$163K | 0.16% | 67 |
|
2024
Q3 | $6.43M | Buy |
+7,255
| New | +$6.43M | 0.17% | 60 |
|
2024
Q2 | – | Sell |
-7,172
| Closed | -$5.58M | – | 261 |
|
2024
Q1 | $5.58M | Buy |
+7,172
| New | +$5.58M | 0.17% | 62 |
|
2023
Q4 | – | Sell |
-2,536
| Closed | -$1.36M | – | 233 |
|
2023
Q3 | $1.36M | Buy |
2,536
+363
| +17% | +$195K | 0.05% | 151 |
|
2023
Q2 | $1.02M | Buy |
2,173
+507
| +30% | +$238K | 0.04% | 162 |
|
2023
Q1 | $572K | Buy |
1,666
+251
| +18% | +$86.2K | 0.02% | 201 |
|
2022
Q4 | $518K | Sell |
1,415
-67
| -5% | -$24.5K | 0.02% | 211 |
|
2022
Q3 | $479K | Sell |
1,482
-6
| -0.4% | -$1.94K | 0.02% | 210 |
|
2022
Q2 | $482K | Sell |
1,488
-154
| -9% | -$49.9K | 0.02% | 222 |
|
2022
Q1 | $470K | Buy |
1,642
+143
| +10% | +$40.9K | 0.02% | 242 |
|
2021
Q4 | $414K | Buy |
1,499
+32
| +2% | +$8.84K | 0.01% | 257 |
|
2021
Q3 | $339K | Sell |
1,467
-153
| -9% | -$35.4K | 0.01% | 268 |
|
2021
Q2 | $372K | Buy |
1,620
+77
| +5% | +$17.7K | 0.01% | 273 |
|
2021
Q1 | $288K | Buy |
1,543
+488
| +46% | +$91.1K | 0.01% | 267 |
|
2020
Q4 | $178K | Buy |
1,055
+8
| +0.8% | +$1.35K | 0.01% | 243 |
|
2020
Q3 | $155K | Sell |
1,047
-12
| -1% | -$1.78K | 0.01% | 234 |
|
2020
Q2 | $174K | Sell |
1,059
-256
| -19% | -$42.1K | 0.02% | 209 |
|
2020
Q1 | $182K | Sell |
1,315
-789
| -38% | -$109K | 0.03% | 193 |
|
2019
Q4 | $277K | Buy |
2,104
+329
| +19% | +$43.3K | 0.04% | 185 |
|
2019
Q3 | $199K | Buy |
+1,775
| New | +$199K | 0.02% | 257 |
|